US 12203098
Cells having solid tumor targeting backbone and use thereof
granted A61KA61K39/39558A61K40/11
Quick answer
US patent 12203098 (Cells having solid tumor targeting backbone and use thereof) held by Fate Therapeutics, Inc. expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Fate Therapeutics, Inc.
- Grant date
- Tue Jan 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K39/39558, A61K40/11, A61K40/31, A61K40/4202